HomeCompareTSYY vs JNJ

TSYY vs JNJ: Dividend Comparison 2026

TSYY yields 311.77% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TSYY wins by $1964.33M in total portfolio value
10 years
TSYY
TSYY
● Live price
311.77%
Share price
$3.47
Annual div
$10.82
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1964.35M
Annual income
$1,204,413,740.20
Full TSYY calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — TSYY vs JNJ

📍 TSYY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTSYYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TSYY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TSYY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TSYY
Annual income on $10K today (after 15% tax)
$26,500.45/yr
After 10yr DRIP, annual income (after tax)
$1,023,751,679.17/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, TSYY beats the other by $1,023,750,975.56/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TSYY + JNJ for your $10,000?

TSYY: 50%JNJ: 50%
100% JNJ50/50100% TSYY
Portfolio after 10yr
$982.19M
Annual income
$602,207,283.99/yr
Blended yield
61.31%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

TSYY
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TSYY buys
0
JNJ buys
0
No recent congressional trades found for TSYY or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTSYYJNJ
Forward yield311.77%3.36%
Annual dividend / share$10.82$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$1964.35M$20.0K
Annual income after 10y$1,204,413,740.20$827.78
Total dividends collected$1889.08M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TSYY vs JNJ ($10,000, DRIP)

YearTSYY PortfolioTSYY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$41,877$31,177.00$10,676$355.77+$31.2KTSYY
2$166,827$122,018.64$11,407$389.39+$155.4KTSYY
3$632,795$454,290.06$12,198$426.53+$620.6KTSYY
4$2,287,536$1,610,445.59$13,056$467.62+$2.27MTSYY
5$7,888,520$5,440,856.00$13,987$513.12+$7.87MTSYY
6$25,975,927$17,535,210.84$14,998$563.56+$25.96MTSYY
7$81,758,070$53,963,828.31$16,098$619.52+$81.74MTSYY
8$246,218,275$158,737,139.95$17,295$681.69+$246.20MTSYY
9$710,223,989$446,770,435.05$18,599$750.82+$710.21MTSYY
10$1,964,353,409$1,204,413,740.20$20,022$827.78+$1964.33MTSYY

TSYY vs JNJ: Complete Analysis 2026

TSYYStock

The Fund’s primary investment objective is to achieve 2 times (200%) the income generated from selling options on Tesla Inc. (NASDAQ TSLA) (the “Underlying Stock”) by selling options on leveraged exchange-traded funds designed to deliver 2 times (200%) the daily performance of the Underlying Stock (the “Underlying Leveraged ETF”). The Fund’s secondary investment objective is to gain exposure to the performance of the Underlying Leveraged ETF, subject to a cap on potential investment gains. A downside protection may be implemented which could affect the net income level.

Full TSYY Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this TSYY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TSYY vs SCHDTSYY vs JEPITSYY vs OTSYY vs KOTSYY vs MAINTSYY vs ABBVTSYY vs MRKTSYY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.